Resultados da busca - Jonathan D. Cuda

  • Mostrando 1 - 5 resultados de 5
Refinar Resultados
  1. 1
    Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system

    Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system por Lysandra Voltaggio, Ashley Cimino‐Mathews, Justin A. Bishop, Pedram Argani, Jonathan D. Cuda, Jonathan I. Epstein, Ralph H. Hruban, George J. Netto, Mark H. Stoler, Janis M. Taube, Russell Vang, William H. Westra, Elizabeth A. Montgomery

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade

    Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade por Genevieve J. Kaunitz, Manisha J. Loss, Hira Rizvi, Sowmya Ravi, Jonathan D. Cuda, Karen B. Bleich, Jessica Esandrio, Inbal Sander, Dung T. Le, Luis A. Díaz, Julie R. Brahmer, Charles G. Drake, Travis J. Hollmann, Mario E. Lacouture, Matthew D. Hellmann, Evan J. Lipson, Janis M. Taube

    Publicado em 2017
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Melanoma subtypes demonstrate distinct PD-L1 expression profiles

    Melanoma subtypes demonstrate distinct PD-L1 expression profiles por Genevieve J. Kaunitz, Tricia R. Cottrell, Mohammed Lilo, Valliammai Muthappan, Jessica Esandrio, Sneha Berry, Haiying Xu, Aleksandra Ogurtsova, Robert A. Anders, Alexander H. Fischer, Stefan Kraft, Meg R. Gerstenblith, Cheryl L. Thompson, Kord Honda, Jonathan D. Cuda, Charles G. Eberhart, James T. Handa, Evan J. Lipson, Janis M. Taube

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab

    Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab por Nicolás A. Giraldo, Peter Nguyen, Elizabeth L. Engle, Genevieve J. Kaunitz, Tricia R. Cottrell, Sneha Berry, Benjamin Green, Abha Soni, Jonathan D. Cuda, Julie E. Stein, Joel Sunshine, Farah Succaria, Haiying Xu, Aleksandra Ogurtsova, Ludmila Danilova, Candice D. Church, Natalie J. Miller, Steve Fling, Lisa Lundgren, Nirasha Ramchurren, Jennifer H. Yearley, Evan J. Lipson, Mac Cheever, Robert A. Anders, Paul Nghiem, Suzanne L. Topalian, Janis M. Taube

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  5. 5
    Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC)

    Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) por Tricia R. Cottrell, Elizabeth D. Thompson, Patrick M. Forde, Julie E. Stein, Amy S. Duffield, Valsamo Anagnostou, Natasha Rekhtman, Robert A. Anders, Jonathan D. Cuda, Peter B. Illei, E Gabrielson, Frederic B. Askin, Noushin Niknafs, Kellie N. Smith, Moises J. Velez, Jennifer L. Sauter, James M. Isbell, David R. Jones, Richard J. Battafarano, Stephen C. Yang, L. Danilova, Jedd D. Wolchok, Suzanne L. Topalian, Victor E. Velculescu, Drew M. Pardoll, Julie R. Brahmer, Matthew D. Hellmann, Jamie E. Chaft, Ashley Cimino‐Mathews, Janis M. Taube

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: